alexa Translational Neurology In Amyotrophic Lateral Sclerosis: Focus On Studies Of Schwann Cells-related To The Disease Mechanisms
ISSN: 2161-1025

Translational Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference on Translational & Personalized Medicine
August 05-07, 2013 Holiday Inn Chicago-North Shore, IL, USA

Gerson Chadi
KeyNote: Transl Med
DOI: 10.4172/2161-1025.S1.007
Abstract
Amyotrophic Lateral Sclerosis (ALS) is the most common motor neuron disease, affecting 0.3-2.5 cases/ year/100,000 persons, characterized by adult-onset degeneration of the upper and lower motor neurons, and fatal in 2-3 years. Five percent of the cases are familiar form mainly linked to a SOD1 gene mutation. Studies on mechanisms of the disease and target drug have been performed mainly in the transgenic animal model (TG) carrying the mutant human SOD1 gene, expecting the molecular mechanisms giving rise to the disease might eventually translate into new treatment options. However, clinical translation of the proposed therapies has been failed. Recent studies have described astrocyte toxicity to motoneurons (MN) in ALS, via a mechanism involving secretion of uncharacterized factors that opened up the possibility for the involvement of other glial cell type in the physiopathology of the disease, for instance the Schwann cells (SC). In fact, astrocyte and SC execute similar functions centrally and peripherally, respectively, in physiological and pathological situations. Rather animal cells might beneficiate SOD1-model studies; restrictions are raised in the context of sporadic forms of ALS. Thus, employment of human cells from patients would be more efficient regarding translation. Here we used human SC from biopsies (Ethic Committee # 0187/11) of extensor hallucis brevis nerve from sporadic form of ALS patients (n=5) in the initial phase of the disease without showing neurological signs on that limb, and surgical fragment of the nerves obtained during reparation of lesioned brachial plexuses of control patients (n=3). SC cultures were performed according to a method developed in our laboratory, resulting in a highly purified human SC culture (96.5%). Co-cultures were performed by plating a highly purified mouse spinal cord MN cultures (81% imunolabeled ChAT positive cells) derived from P1 neonates above the monolayer of SCs. Neuronal death was quantified by Fluoro Jade C at the culture day five. The RNA of ALS patient nerves and controls was extracted and the microarray analysis of the whole human genome was performed, and analyzed by means GeneSpring GX software (Agilent) and DAVID Bioinformatics Resource. SC from ALS patients triggered a massive death of MN from wild-type (10-fold) and TG (7-fold) mice compared to SC of control patients. Gene expression profiling in the nerve of ALS patients have placed to discover pathways of disease pathogenesis in the SC/MN, favoring potential therapeutic target and biomarker development.
Biography
Gerson Chadi M.D., has completed his Ph.D. at the age of 30 years from University of Sao Paulo and postdoctoral studies from Institute Karolinska and University of Toronto. He is a full time Professor, since 1997, of the Experimental Neurology, Department of Neurology, University of Sao Paulo Medical School, responsible for Translational Neurology Program in his Department. He has published more than 68 papers in reputed journals.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords